Breast

Most recent

New Strategies in the Treatment of HER2-Positive Breast Cancer

NE Oncology Issue - February 2014 Breast cancer Overexpression of the human epidermal growth factor receptor 2 (HER2) protein is detected in the tumours of approximately 20% of patients with breast cancer, conferring an aggressive phenotype...

Confirmatory overall survival analysis of CLEOPATRA: a randomized, doubleblind, placebo-controlled phase III study with pertuzumab, trastuzumab, and docetaxel in patients with HER2-positive first-line metastatic breast cancer

NE Oncology Issue - April 2013 Swain S, et al. SABCS 2012:P5-18-26 Background The CLEOPATRA (Clinical Evaluation of Pertuzumab and Trastuzumab) study randomized patients with human epidermal growth factor receptor 2 (HER2)- positive first-line metastatic breast cancer...

Twitter feed

Local #radiotherapy improves OS in metastatic #prostatecancer with low disease burden. #ESMO18 https://t.co/RCbjG89hYS
h J R
#Immunotherapy as first-line treatment in some metastatic #colorectal #cancers? #ESMO18 https://t.co/Pl4prgsFo0
h J R
Genetic marker of #pancreaticcancer may predict #radiation therapy outcomes. https://t.co/RIjInoqOmD
h J R
A shortcut to #cancer drug development: live tumour testing. https://t.co/dYZmtRqMhX
h J R
New #cancer #vaccine shows early promise for patients with #HER2-positive cancers. https://t.co/kjLaFxdsbJ
h J R

Other

Twitter feed

Local #radiotherapy improves OS in metastatic #prostatecancer with low disease burden. #ESMO18 https://t.co/RCbjG89hYS
h J R
#Immunotherapy as first-line treatment in some metastatic #colorectal #cancers? #ESMO18 https://t.co/Pl4prgsFo0
h J R
Genetic marker of #pancreaticcancer may predict #radiation therapy outcomes. https://t.co/RIjInoqOmD
h J R
A shortcut to #cancer drug development: live tumour testing. https://t.co/dYZmtRqMhX
h J R
New #cancer #vaccine shows early promise for patients with #HER2-positive cancers. https://t.co/kjLaFxdsbJ
h J R